Emergent BioSolutions
EBS
#8180
Rank
โ‚น33.15 B
Marketcap
โ‚น646.61
Share price
-5.68%
Change (1 day)
-41.60%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): -โ‚น327.18

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -โ‚น326.63. In 2025 the company made an earnings per share (EPS) of โ‚น90.20 an increase over its 2024 EPS that were of -โ‚น344.67.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น327.18-462.72%
2025โ‚น90.20-126.17%
2024-โ‚น344.67-75.61%
2023-โ‚น1,413232.21%
2022-โ‚น425.38-203.46%
2021โ‚น411.13-25.09%
2020โ‚น548.81445.28%
2019โ‚น100.65-15.2%
2018โ‚น118.69-35.9%
2017โ‚น185.1569.57%
2016โ‚น109.19-27.67%
2015โ‚น150.9765.63%
2014โ‚น91.1511.63%
2013โ‚น81.6632.31%
2012โ‚น61.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น72.16-122.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น120.16-136.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น303.62-192.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚น170.91-47.67%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น50.32-115.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น413.03 26.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น59.82-118.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel